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Abstract
One of the most important and challenging problems in biomedicine and genomics is how to identify the disease genes. In
this study, we developed a computational method to identify colorectal cancer-related genes based on (i) the gene
expression profiles, and (ii) the shortest path analysis of functional protein association networks. The former has been used
to select differentially expressed genes as disease genes for quite a long time, while the latter has been widely used to study
the mechanism of diseases. With the existing protein-protein interaction data from STRING (Search Tool for the Retrieval of
Interacting Genes), a weighted functional protein association network was constructed. By means of the mRMR (Maximum
Relevance Minimum Redundancy) approach, six genes were identified that can distinguish the colorectal tumors and
normal adjacent colonic tissues from their gene expression profiles. Meanwhile, according to the shortest path approach,
we further found an additional 35 genes, of which some have been reported to be relevant to colorectal cancer and some
are very likely to be relevant to it. Interestingly, the genes we identified from both the gene expression profiles and the
functional protein association network have more cancer genes than the genes identified from the gene expression profiles
alone. Besides, these genes also had greater functional similarity with the reported colorectal cancer genes than the genes
identified from the gene expression profiles alone. All these indicate that our method as presented in this paper is quite
promising. The method may become a useful tool, or at least plays a complementary role to the existing method, for
identifying colorectal cancer genes. It has not escaped our notice that the method can be applied to identify the genes of
other diseases as well.
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Introduction
Colorectal cancer (CRC) is one of the most common
malignancies in the western countries and a major cause of
cancer-related death. Early detection of CRC could reduce the
morbidity and improve the prognosis. Therefore, it is of great
importance to identify cancer-related genes that could be used as
biomarker for early diagnosis.
Recently, with the development of high-throughput biotechnol-
ogies, a large amount of biological data has been generated, such
as yeast two-hybrid systems, protein complex and gene expression
profiles, etc. These data are useful resources for deducing and
understanding gene functions [1,2,3,4,5,6,7,8]. So far the protein-
protein interaction (PPI) data has been widely used for gene
function prediction with the assumption that interacting proteins
share the same or have similar functions and hence may be
involved in the same pathway. This ‘‘guilty by association’’ rule
was first proposed by Nabieva et al. [9] and can also be used to
identify cancer related genes.
STRING is an online database resource which is an
abbreviation for Search Tool for the Retrieval of Interacting
Genes [10]. It provides both experimental as well as predicted
interaction information with a confidence score. Algorithms based
on PPI suggest that proteins with short distances to each other in
the network are more likely to share the common biological
functions [11,12,13,14], and that interactive neighbors are more
likely to have identical biological function than non-interactive
ones [15,16]. This is because the query protein and its interactive
proteins may form a protein complex to perform a particular
function or involved in a same pathway.
Although the successful application of the high-throughput data
for gene function perdition and identification of novel genes
associated with cancers, the errors in the high-throughput data
have not been well solved yet. In this paper, we proposed a new
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expression profile and a weighted functional protein association
network constructed with PPI data from STRING. This method
can make up the defect of only using high-throughput data.
Meanwhile, the mRMR (maximum relevance minimum re-
dundancy) algorithm [17] was utilized to identify six promising
candidate genes distinguishing tumor and the normal colorectal
samples. The Dijkstra’s algorithm [18] was used to construct the
shortest paths between each pair of the six genes. Moreover,
additional 35 genes on these shortest paths were also identified and
analyzed. For such (6z35)~41 gene thus identified, it was
observed that they contained more cancer genes than the genes
identified from the gene expression profiles alone. Furthermore,
the 41 genes also had greater functional similarity with the
reported CRC genes than the genes identified from gene
expression profiles alone. It is anticipated that some of the 41
genes thus identified might belong to novel CRC related genes.
Materials and Methods
Dataset
Weusedthegeneexpressiondatafromthecolorectalcancerstudy
of Hinoue et al. [19]. The gene expression profiling of 26 colorectal
tumors and matched histologically normal adjacent colonic tissue
samples were retrieved from NCBI Gene Expression Omnibus
(GEO) with the accession number of GSE25070. The gene
expression profile was obtained using the Illumina Ref-8 whole-
genome expression BeadChip with 24526 probes corresponding to
18491 genes. Signal intensity was log2 transformed and then
normalized with RSN (Robust Spline Normalization) method.
Tissue sample representation
Based on the above, the representation of a tissue sample can be
formulated as a 24526-D (dimensional vector), as given by
P~ y1 y2     yu     y24526 ½ 
T ð1Þ
where P represents the tissue sample, yu the value of it’s u-th
probe, and T the transpose matrix (cf. Eq.6 of [20]).
Cancer related gene list and two colorectal cancer
related gene lists
We compiled three gene lists from public databases and
published works to compare with the 41 candidate genes we
identified. These three genes lists included one cancer related gene
list and two colorectal cancer related gene lists.
742 cancer-related genes were derived from three sources. First,
we obtained 457 cancer-related genes from the Cancer Gene
Census of the Sanger Centre. Secondly, we retrieved cancer-
related genes from the Atlas of Genetics and Cytogenetic in
Oncology [21]. The third part was collected from the Human
Protein Reference Database [22]. See Supporting Information S1.
The firstcolorectalcancerrelated genelistwasretrievedfrom the
study of Sabates-Bellver and coworkers [23]. They compared the
transcriptomes of 32 adenomas with normal mucosa from the same
individuals and identified 438 genes with markedly altered
expression in colorectal adenomas compared with normal mucosa
with Affymetrix U133 Plus 2.0 array. See Supporting Informa-
tion S1.
The second colorectal cancer related gene list was retrieved
form a recent work of Nagaraj et al. [24]. They proposed
a Boolean based systems biology approach with guilt-by-
association algorithm to identify novel cancer-associated genes.
We compiled all the 134 novel CRC related genes identified in this
study. See Supporting Information S1.
PPI data from STRING
The initial weighted PPI network was retrieved from STRING
(version9.0)[10](http://string.embl.de/), whichisalargedatabase
of known and predicted protein interactions. Proteins in the
interaction network were represented with nodes, while the
interaction between any two proteins therein was represented with
an edge. These interactions contain direct (physical) and indirect
(functional) interactions, derived from numerous sources such as
experimental repositories, computational prediction methods. In
the network, each edge is marked with a score to quantify the
interaction confidence, i.e., the likelihood that an interaction may
occur.
The mRMR (maximum relevance minimum redundancy)
method
To find the genes that can distinguish colorectal tumors and
normal adjacent tissues, we used the mRMR method, which was
originally developed by Peng et al. [17] for analyzing the
microarray data. The mRMR method could rank genes according
to their relevance to the class of samples concerned, and
meanwhile also could take the redundancy of genes into account.
Those genes, which have the best trade-off between the maximum
relevance to the sample class and the minimum redundancy, were
considered as ‘‘good’’ biomarkers.
Both the relevance and redundancy were quantified by the
following mutual information (MI):
I(x,y)~
ð ð
p(x,y)log
p(x,y)
p(x)p(y)
dxdy ð2Þ
where x and y are vectors, p(x,y) is their joint probabilistic
density, and p(x) and p(y) are the marginal probabilistic densities.
To quantify both the relevance and redundancy, let us define V
as the whole gene set, VS as the already-selected gene set
containing m genes and Vt as the to-be-selected gene set
containing n genes. The relevance D between the gene f in Vt
and the target c can be calculated by:
D~I(f,c) ð3Þ
The redundancy R between the gene f in Vt and all the genes in
Vs can be calculated by:
R~
1
m
X
fi[Vs
I(f,fi) ð4Þ
In order to obtain the gene fi in Vt with the maximum relevance
and minimum redundancy, let us combine Eq.3 and Eq.4, as can
be formulated as follows:
max
fj[Vt
I(fj,c){
1
m
X
fi[Vs
I(fj,fi)
2
4
3
5 (j~1,2,   ,n) ð5Þ
Given a gene set with N(~mzn) genes, the mRMR operation for
the gene evaluation will continue N rounds. After these
evaluations, the mRMR method will generate a gene set S as
formulated by
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0
,f2
0
,   ,fh
0
,   ,fN
0 no
ð6Þ
where the index h(1, 2,    , N) indicates which round the gene is
selected. The smaller the index h is, the earlier the gene satisfied
Eq.5 and the better the gene is.
Prediction engine
In this study, the Nearest Neighbor Algorithm (NNA) [25,26],
which has been widely used in bioinformatics and computational
biology [3,27,28,29,30,31,32,33,34], was adopted to predict the
class of colorectal tissue samples. The ‘‘nearness’’ was calculated
according to the following equation
D(P1,P2)~1{
P1,P2
P1 kk : P2 kk
ð7Þ
where P1 and P2 are two vectors representing two tissue samples,
P1:P2 istheirdotproduct, P1 kk and P2 kk aretheirmoduluses.The
smallertheD(P1,P2),themoresimilarthetwosamplesare[35].For
an intuitive illustration of how NNA works, see Fig.5 of [20].
Performance validation
The following three cross-validation methods are often used in
statistics for validating a statistical prediction method: independent
dataset test, subsampling test, and jackknife test [36]. However,
among the three validation methods, the jackknife test is the least
arbitrary due to the following facts. (i) For the independent dataset
test,althoughallthesamplesusedtotestthepredictorareoutsidethe
training dataset used to train the prediction engine so as to exclude
the ‘‘memory’’ effect or bias, the way of how to select the
independent samples to test the predictor could be quite arbitrary
unless the number of independent samples is sufficiently large. This
kind of arbitrariness might lead to completely opposite conclusions.
Forinstance,theconclusionthatapredictoryieldedahighersuccess
rate than the other predictor for a given independent testing dataset
might become just opposite when tested by another independent
testing dataset [36]. (ii) For the subsampling test, the concrete
procedure usually used in literatures is the 5-fold, 7-fold or 10-fold
cross-validation. The problem with this kind of subsampling test is
that the number of possible selections in dividing a benchmark
datasetisextremelylargeevenforaverysimpleandsmalldataset,as
elucidated in [37] and demonstrated by Eqs.28–30 in [20].
Therefore, in any actual subsampling cross-validation tests, only
a very tiny fraction of the possible selections are taken into account.
Since different selections will always result in different outcomes
even for a same benchmark dataset and a same predictor, the
subsamplingtestcannotavoidthearbitrarinesseither.Atestmethod
unabletoyieldauniqueoutcomecannotberegardedasagoodone.
(iii)Inthejackknifetest,allthesamplesinthebenchmarkdatasetwill
be singled out one-by-one and tested by the predictor trained by the
remaining samples. During the process of jackknifing, both the
training dataset and testing dataset are actually open, and each
samplewillbeinturnmovedbetweenthetwo.Thejackknifetestcan
exclude the ‘‘memory’’ effect. Also, the arbitrariness problem as
mentioned above for the independent dataset test and subsampling
test can be avoided because the outcome obtained by the jackknife
testisalwaysuniqueforagivenbenchmarkdataset.Accordingly,the
jackknife test has been widely and increasingly used to inspect the
quality of various predictors (see, e.g.,
[30,31,32,38,39,40,41,42,43,44,45,46]). Accordingly, in this study
the jackknife test was also used to examine the quality of the current
prediction method.
The prediction accuracy was formulated by
Accuracy~
TPzTN
TPzTNzFPzFN
ð8Þ
where TP represents the true positive; TN, the true negative; FP,
the false positive; and FN, the false negative.
Incremental feature selection (IFS)
Based on the ranked genes according to their importance after
mRMRevaluation,weusedtheIncrementalFeatureSelection(IFS)
(see, e.g., [1,47]) to determine the optimal number of genes as
biomarkers. During the IFSprocedure, genes inthe ranked gene set
are added one by one from higher to lower rank. A new gene set is
composed when one gene is added. Thus N gene sets would be
composed when given N ranked genes. Thei-th gene set is
Si~ff1,f2,   ,fig (1ƒiƒN) ð9Þ
For each of the N gene sets, an NNA predictor was constructed and
examined using the jackknife test to the benchmark dataset. By
doing so we obtained an IFS table with one column for the index i
and another column for the prediction accuracy. Thus, we could
obtaintheoptimalgeneset(Soptimal),withwhichthepredictorwould
yield the best prediction accuracy.
Graph approach and shortest paths tracing
Graphs are a useful vehicle for studying complex biological
systems because they can provide intuitive insights and the overall
structure property, as demonstrated by various studies on a series of
important biological topics (see, e.g.,
[48,49,50,51,52,53,54,55,56,57,58]). In this study, we first con-
structed a graph G(V, E) with the PPI data from STRING. In the
graph, an edge was assigned for each pair of genes if they were in
interaction with each other. The weight of edge E in graph G was
derived from the confidence score according to the equation
wG~1000|(1{w0),wherewG istheweightingraphGwhilew0 is
the confidence score between two proteins concerned. Thus, we get
afunctionalproteinassociationnetworkwithedgeweight.Dijkstra’s
algorithm[18]wasusedtofindtheshortestpathfromeachofthesix
genes to all the other five genes in the graph. Then we picked out all
the genes existing in the shortest paths and rank these genes
according to their betweenness.
KEGG enrichment analysis
Functional annotation tool of DAVID [59] was used for KEGG
pathway enrichment analysis. The enrichment p-value was
corrected to control family-wide false discovery rate under certain
rate (e.g., #0.05) with Benjamin multiple testing correction
method [60]. All the genes on the BeadChip were selected as
background during the enrichment analysis.
Results
mRMR results
The expression profile was retrieved from GEO with the
accession number of GSE25070, which contained 52 samples and
24,526 probes and was transformed to a CSV file with 52 rows
and 24526 columns as the input of mRMR. Each probe
represented a feature and the 26 tumor samples belonged to class
1 while the paired26 paired normal samples belonged to class 2.
After running the mRMR software, we obtained two tables (see
Supporting Information S2), of which one was called MaxRel
Identification of Colorectal Cancer Related Genes
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class of samples, and the other called mRMR feature table that
listed the probes with the maximum relevance and minimum
redundancy to the class of samples.
Six candidate genes identified by NNA and IFS
On the basis of the outputs of mRMR, we constructed 1000
feature subsets according to Eq.9. As described in the Materials
and Methods section, we tested the predictor with one feature, two
features, three features, etc., and the IFS result can be found in
Supporting Information S3. Shown in Fig. 1 is the IFS curve
plotted based on the data of Supporting Information S3. In the
IFS curve, the X-axis is the number of probes used for
classification, and the Y-axis is the prediction accuracies of the
nearest neighbor algorithm evaluated by the jackknife test. The
maximum accuracy was 1 when 6 features were included. The
optimal probe set included 6 probes corresponding to 6 different
genes, which were GUCA2B, PI16, CDH3, SPIB, BEST2, and
HMGCLL1 (Table 1).
Shortest paths genes
Meanwhile, we constructed an undirected graph with the PPI
data from STRING. Then we picked out two genes from the six
genes identified with the mRMR method as described above, and
found out the shortest path between these two genes with the
Dijkstra’s algorithm. We obtained a total of 15 shortest paths with
lowest cost (Supporting Information S4). Shown in Fig. 2 are the
15 shortest paths between the six candidate genes, where the
interaction confidence was labeled on the edge for each of the
interaction gene pairs. There were a total of 35 genes on the
shortest paths and we ranked these genes according to their
betweenness (Table 2). Among these 35 genes, AR has the largest
betweenness of 7, meaning that there are 7 shortest paths going
through this gene. Accordingly, AR may play an important role in
connecting the six candidate genes and hence may be related to
CRC. Such a conclusion is fully consistent with the fact that AR
protein was found in normal colorectal mucosa as well as in most
CRC [61,62], implying that the AR receptor is responsible for the
mitogenic effects of the hormone as will be further discussed later.
To test whether our 35 shortest path genes were hubs in the
background network or not, we ran a permutation to count the
occurrence time of our 35 shortest path genes in the shortest
paths between 6 random selected genes when they has greater
Figure 1. IFS curve for the colorectal tumors and matched normal adjacent tissue samples classification. In the IFS curve, the X-axis is
for the number of probes used for classification, and the Y-axis for the prediction accuracies by the nearest neighbor algorithm (NNA) evaluated by
the jackknife (Leave-One-Out) cross-validation test. The peak accuracy was 1 with six probes. The top 6 probes in the mRMR probe list formed the
optimal discriminative probe set.
doi:10.1371/journal.pone.0033393.g001
Table 1. mRMR top six genes.
order Probe name Symbol EntrezID Protein ID
1 ILMN_1735578 GUCA2B 2981 ENSP00000361662
2 ILMN_1766264 PI16 221476 ENSP00000362778
3 ILMN_1704294 CDH3 1001 ENSP00000264012
4 ILMN_2143314 SPIB 6689 ENSP00000270632
5 ILMN_1755796 BEST2 54831 ENSP00000042931
6 ILMN_2339192 HMGCLL1 54511 ENSP00000381654
doi:10.1371/journal.pone.0033393.t001
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5000 times, and the p-value was calculated as the proportion of
occurrence time of the 35 genes in 5000 permutation. For detail,
please see Table 2. There were 10 shortest path genes whose p-
values were not significant. TP53 was a star molecular involved
in numerous biological processes and nearly related to all kinds
of cancers [63]. Therefore, it is nothing surprising that TP53
appeared many times in shortest path between 6 randomly
picked genes. For EP300, it has been reported that this gene can
acetylate TP53 and associated with lots of tumors [64].
CTNNB1 and GSK3B belong to the Wnt signaling pathway,
the role of which in caners has been well documented [65]. For
the remaining insignificant 6 genes, their betweennesses in our
study were all one (Table 2), and hence the number of
occurrences for these genes in random shortest paths is prone to
be greater than one. Most of these insignificant 6 shortest path
genes fall behind in Table 2 according to their betweennesses,
suggesting that they might not be important. Besides these 10
genes, the remaining 25 shortest path genes in our study were
identified to be significant.
Figure 2. 15 shortest paths between the six genes identified with mRMR method. The 15 shortest paths between the six candidate genes
were identified with Dijkstra’s algorithm based on the PPI data from STRING. Yellow roundrect represents the top six candidate genes identified by
the mRMR method. Red round represents the 35 genes existing within the range of the shortest paths. Numbers on edges represent the edge
weights to quantify the interaction confidence. The smaller the number is, the stronger the interaction between two nodes is. See the text in the
Section of ‘‘Graph approach and shortest paths tracing’’ for the quantitative relation of the edge weight with the confidence score between two
proteins concerned.
doi:10.1371/journal.pone.0033393.g002
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Using the functional annotation tool of DAVID, the KEGG
pathway enrichment analysis was carried out for the genes
corresponding to the 1000 probes listed in the MaxRel. The
enrichment results showed that these genes were significantly
enriched in the energy metabolism pathways, including fatty acid
metabolism, pentose and glucuronate interconversions, as well as
starch and sucrose metabolism (Table 3). These results suggested
that metabolism of nutrients may play critical role in the
tumorigenesis of CRC.
Six candidate genes and shortest paths genes of KEGG
enrichment
The KEGG pathway enrichment analysis was also performed
on the 41 genes including the top six genes in the mRMR list and
35 genes in the shortest paths between these six genes with the
functional annotation tool of DAVID. The enrichment result thus
obtained showed that these genes were significantly enriched in
the canonic cancer related pathways, such as prostate cancer,
pathways in cancer, Wnt signaling pathway, cell cycle, colorectal
cancer, thyroid cancer, and so on. It is instructive to note that
among these pathways, some have been proved to be relevant to
colorectal cancer including Wnt signaling pathway, cell cycle,
colorectal cancer and insulin signaling pathway (Table 4).
Overlap with cancer related gene list and two CRC
related gene lists
We compiled 742 cancer-related genes from the following three
different sources: Cancer Gene Census from the Sanger Centre,
Atlas of Genetics and Cytogenetic in Oncology [21], and Human
Protein Reference Database [22]. It was observed that 8 out of the
41 genes identified by us were proven to be cancer-related genes.
Also, it was indicated by the Fisher’s exact test that these 41 genes
were significantly related to cancer (p-value=0.0001908). See
Supporting Information S5.
Moreover, we collected 438 genes that were differentially
expressed between colorectal adenomas and normal mucosa from
previous study [23]. Interestingly, the aforementioned 41 candi-
date genes identified by us had an overlap of 4 genes with the 438
genes, and the overlap was quite significant (p-value=0.01057,
Fisher’s exact test). See Supporting Information S5.
Recently, the Boolean based systems biology approach was
employed to identify 134 novel CRC related genes [24], of which
three were identified by us in this study and the overlap was
significant (p-value=0.002017, Fisher’s exact test). See Supporting
Information S5.
Discussion
KEGG enrichment of MaxRel genes
The genes corresponding to the 1000 probes listed in the
MaxRel table were significantly enriched in the energy metabo-
lism pathways, including fatty acid metabolism, pentose and
glucuronate interconversions, as well as starch and sucrose
metabolism. It has been shown that diet has an important effect
on the CRC development. Our finding is quite consistent with the
fact that genetic polymorphisms influencing the metabolism of
nutrients play an important role in the etiology of CRC and
colorectal adenomatous polyps [62].
Multiple lines of evidences have indicated the implication or
involvement of fat in the etiology of CRC [66]. The crucial role of
fatty acids in numerous biological processes suggests that alteration
in fatty acid metabolizing genes contributes to colon carcinogen-
esis [67]. It has been shown that starch and sucrose metabolism
and pentose and glucuronateinterconversions were closely related
to cancers. Christensen et al. [68] demonstrated that starch and
sucrose metabolism and pentose and glucuronateinterconversions
pathway were hypomethylated in isocitrate dehydrogenase mutant
tumors. In addition, these two metabolic pathways were found to
be significantly related to the risk of developing estrogen receptor-
negative breast cancer [69].
A recent CRC disease-specific transcriptome research showed
that starch and sucrose metabolism was one of the 7 common
pathway significant differentially regulated using two different
microarray platforms including Affymetrix HGU133 Plus2.0 array
Table 2. Shortest paths genes.
order Protein id symbol betweenness P-value
1 ENSP00000363822 AR 7 0
*
2 ENSP00000269305 TP53 6 0.3442
3 ENSP00000230354 TBP 5 0.0066
*
4 ENSP00000250003 MYOD1 5 0.0006
*
5 ENSP00000263253 EP300 5 0.0598
6 ENSP00000287936 HMGCR 5 0
*
7 ENSP00000314151 KLK3 5 0
*
8 ENSP00000344456 CTNNB1 5 0.0984
9 ENSP00000344741 INSIG1 5 0
*
10 ENSP00000349508 CHD4 5 0
*
11 ENSP00000351363 MSMB 5 0
*
12 ENSP00000354620 FOXJ3 5 0
*
13 ENSP00000362649 HDAC1 5 0.0108
*
14 ENSP00000396219 MEF2C 5 0
*
15 ENSP00000417884 TRIM27 5 0
*
16 ENSP00000342470 NR1H3 4 0.005
*
17 ENSP00000354476 SREBF2 4 0.0038
*
18 ENSP00000363868 ABCA1 4 0.0098
*
19 ENSP00000361066 NCOA3 3 0.0038
*
20 ENSP00000419692 RXRA 3 0.0098
*
21 ENSP00000324806 GSK3B 2 0.1016
22 ENSP00000399968 NCOA2 2 0.0308
*
23 ENSP00000206249 ESR1 1 0.1968
24 ENSP00000254227 NR0B2 1 0.0346
*
25 ENSP00000262367 CREBBP 1 0.0754
26 ENSP00000265565 SCAP 1 0.0088
*
27 ENSP00000268712 NCOR1 1 0.0176
*
28 ENSP00000297146 GPR85 1 0.0104
*
29 ENSP00000304895 IRS1 1 0.0976
30 ENSP00000329357 SP1 1 0.1242
31 ENSP00000348069 SREBF1 1 0.023
*
32 ENSP00000348551 NCOR2 1 0.0162
*
33 ENSP00000348827 THRB 1 0.0082
*
34 ENSP00000348986 INS-IGF2 1 0.0898
35 ENSP00000353483 MAPK8 1 0.1194
*: P-value,0.05, significant.
doi:10.1371/journal.pone.0033393.t002
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was identified as significantly differentially regulated pathway
using colorectal disease specific array [70].
Six candidate genes identified by mRMR, NNA and IFS
In this study, we have identified the following six genes:
GUCA2B, PI16, CDH3, SPIB, BEST2, and HMGCLL1. Below,
let us briefly discuss their relationships with colorectal cancer.
GUCA2B (uroguanylin) is an endogenous activator of the
guanylate cyclase-2C receptor found to be down regulated 8-fold
in adenoma, and its expression is detected in blood and urine
[71].Therefore, GUCA2B could be regarded as a non-invasive
biomarker for the early detection of CRC. In addition, the radio
labeled uroguanylin analogs have been used for detection of
CRC in vivo [72].
PI16 (Peptidase inhibitor 16) is detected within the testis,
prostate, small intestine, colon, and ovary with immunohisto-
chemical analyses [73]. Decrease of PI16 level was detected in
prostate cancer [73] and gastric cancer [74]. Our result also
showed that the expression of PI16 in colorectal adenocarcinoma
was significant decreased compared with the adjacent non-tumor
colorectal tissue, which was consistent with the result of the
research in prostate cancer and gastric cancer. Since PI16 is not
well characterized and so far there is no report whatsoever about
PI16 in colorectal cancer etiology, our result implied that PI16
may become a promising biomarker for colorectal cancer early
diagnosis.
CDH3 is a classical cadherin, the demethylation of which is
frequently detected in the advanced CRC which was associated
with the overexpression of CDH3 [75]. Besides CRC, CDH3 was
also overexpressed in the majority of pancreatic cancer and gastric
cancer, but not in their noncancerous counterparts or in normal
tissues. Thus CDH3 was regarded as a novel tumor-associated
antigen useful for immunotherapy and early diagnosis of gastric
cancer and CRC [76].
SPIB is a transcription factor of the E-twenty-six (ETS) family,
which is known to act as positive or negative regulators of gene
expression. SPIB is an adenoma condition-specific down regulated
gene and its expression underwent a striking decrease in CRC
tissues indicating that SPIB may serve as potential markers of
CRC invasiveness and metastasis [77].
BEST2 (also known as VMD2L1) encodes a protein of the
bestrophin family. Both RT-PCR analyses and X-gal staining
revealed tissue-restricted BEST2 and VMD2L2 abundantly
expressed in colon [78,79]. It has been show that BEST2
mediates bicarbonate transport by goblet cells in mouse colon
[80]. Straub et al. [81] identified BEST2 as one of the methylation
markers for early detection and prognosis of CRC. Therefore,
BEST2 was expected to become a therapy target for CRC with
demethylation agent.
HMGCLL1 has been show to be related to various cancers,
such as pancreatic cancers [82], glioblastoma multiforme [83],
breast and colorectal cancers [84]. HMGCLL1 is one of the genes
containing somatic mutations in pancreatic cancer [82]. Though
mutation in HMGCLL1 has been reported to be involved in these
cancers, the specific mechanisms underlying remain to be
elucidated.
Table 3. MaxRel table genes KEGG enrichment.
Term KEGG ID Count
a Percentage
b P-value Benjamini Adjusted P-Value
Fatty acid metabolism 00071 11 1.2 8.4E-5 1.5E-2
Pentose and glucuronate
interconversions
00040 7 0.8 3.0E-4 2.7E-2
Starch and sucrose metabolism 00500 10 1.1 6.6E-4 3.8E-2
aThe number of genes belonging to a certain pathway.
bThe percentage of genes belonging to a certain pathway account for all the genes underwent KEGG pathway analysis.
doi:10.1371/journal.pone.0033393.t003
Table 4. mRMR top six genes and shortest path genes KEGG enrichment.
Term KEGG ID Count
a Percentage
b P-value
Benjamini Adjusted
P-Value
Prostate cancer 05215 8 19.5 3.80E-08 2.40E-06
Pathways in cancer 05200 10 24.4 2.60E-06 8.00E-05
Wnt signaling pathway 04310 6 14.6 3.00E-04 6.30E-03
Huntington’s disease 05016 6 14.6 6.70E-04 1.10E-02
Notch signaling pathway 04330 4 9.8 8.80E-04 1.10E-02
Cell cycle 04110 5 12.2 1.50E-03 1.60E-02
Insulin signaling pathway 04910 5 12.2 2.00E-03 1.80E-02
Colorectal cancer 05210 4 9.8 4.70E-03 3.60E-02
Thyroid cancer 05216 3 7.3 6.20E-03 4.20E-02
Melanogenesis 04916 4 9.8 7.40E-03 4.60E-02
aThe number of genes belonging to a certain pathway.
bThe percentage of genes belonging to a certain pathway account for all the genes underwent KEGG pathway analysis.
doi:10.1371/journal.pone.0033393.t004
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We totally identified 35 shortest paths genes. As we can see from
Table 2, some shortest path genes such as TP53, EP300,
CTNNB1 and GSK3B were not significant for CRC due to their
universality in numerous cancers. However, these genes have been
well documented to be relevant to CRC, and also their role in
CRC has been well characterized [85]. Besides these genes, most
of the other shortest genes listed in Table 2 were quite specific to
CRC (p-value,0.05). Below, let us focus on the specific genes with
the large betweenness values and discuss the relationship of such
genes with CRC.
AR (androgen receptor) is a ligand dependent transcription
factor, which is involved in the control of cellular proliferation and
differentiation [86]. Several studies have provided supporting
evidences for its involvement of sex steroid hormones (estrogens
and androgens) in the etiology and progression of CRC [87]. AR
protein has been shown to be expressed in normal colorectal
mucosa and in most colorectal cancer [61,62], supporting that
CRC expressing the AR receptor may respond to mitogenic effects
of the hormone. Moreover, somatic reductions of the androgen
receptor CAG repeat occur frequently, through a pathway
different from microsatellite instability and early during colon
carcinogenesis. Apparent growth selection of cells harboring
shortened AR alleles suggests that androgens contribute to colon
carcinogenesis in a yet unknown way [61].
TBP (the TATA-binding protein) is a key eukaryotic transcrip-
tion factor used by all three cellular RNA polymerases. Compared
to normal colon epithelium, TBP expression is elevated in the case
of human colon carcinomas. Both Ras-dependent and Ras-
independent mechanisms mediate the increases of TBP expression
in colon carcinoma cell lines. Thus, TBP may be a crucial
component in dysregulated signaling for causing tumors [88].
MYOD1 promoter methylation occurs in various malignancies
including CRC. MYOD1 promoter methylation was detectable in
tumor and normal colorectal samples, but was significantly higher
in tumor than in normal mucosa. Patients without MYOD1
hypermethylation showed significantly longer survival than those
with hypermethylation. Therefore, MYOD1 hypermethylation
plays an important role in CRC and may be a novel prognostic
factor [89].
HMGCR (3-hydroxy-3-methylglutaryl coenzyme A reductase)
is an enzyme that catalyzes the rate-limiting step of cholesterol
biosynthesis. HMGCR alternative splicing of exon 13 is not only
a biomarker, but also a determinant of statin efficacy, which is
a class of cholesterol-lowering drugs that inhibit HMGCR.
HMGCR was used not only for the treatment of hypercholester-
olemia, but also as a chemopreventive agent for CRC [90]. A
genetic test of HMGCR was utilized to determine in which
patients cholesterol-lowering statin drugs might have the most
benefit in reducing the risk of CRC. A recent research has found
a genetic variant may affect the way of how statins control both
colorectal cancer and cardiovascular disease risk [91].
KLK3 (also known as prostate-specific antigen, PSA) is
a kallikrein-like serine protease that is a widely used biomarker
for prostate cancer [92]. In addition to prostate cancer, breast,
colon, ovarian, liver and kidney tumors can also produce KLK3
[93]. Recently, several other members of KLK family like KLK7
have shown promise as potential biomarkers for various cancers
including colon cancer [94,95,96]. Thus, with the progress of
research, KLK3 may become a biomarker for CRC as well.
CHD (Chromodomain helicase DNA-binding protein) is
a regulator of the chromatin remodeling process. CHD4
expression was detected in gastric cancers and CRCs by
immunohistochemistry. It has been reported that loss of CHD4
expression was observed in 56.4% of the gastric cancers and
55.7% of the CRCs. In addition, Frameshift mutation and loss of
expression of CHD genes are common in gastric cancers and
CRCs with MSI-H. These alterations might contribute to cancer
pathogenesis by deregulating CHD-mediated chromatin remodel-
ing [97].
MSMB encodesb-microsemino protein, which is a proposed
biomarker for prostate cancer [98]. Genome-wide association
studies (GWAS) have identified a variant, rs10993994, on
chromosome 10q11 which is associated with prostate cancer risk.
So far, there is no report about MSMB in CRC etiology.
However, the expression of MSMB was detected in colon
epithelial cells by immunohistochemistry [99]. Thus, it may be
a potential biomarker for colorectal cancer diagnosis although it is
remained to be verified.
FOXJ3 is a member of Human Forkhead-box (FOX) gene
family. It has been shown that genetic and epigenetic changes of
FOX family genes as well as alterations occurring in target genes
of FOX transcription factors family could lead to human disease
including carcinogenesis [100]. Recently, Niittymaki et al. [101]
identified a SNP, rs2761880, locates in the binding site of FOXJ3
in CRC. It has been proposed that many of the predisposition loci
for CRC are involved in control of gene expression by targeting
transcription factor binding sites. In addition, oligonucleotide
microarray analysis of distinct gene expression patterns in CRC
tissues harboring BRAF and K-ras mutations has shown that
FOXJ3 was identified by PAM (Prediction analysis of microarrays)
and the jackknife (or leave-one-out) cross validation as candidate
to distinguish the mutant groups [102].
HDAC1 (Histone deacetylase 1) is involved in tumorigenesis
through their regulation of cell proliferation, differentiation and
survival. In cancer cells, HDAC1 represses the expression of tumor
suppress genes such as p21/WAF1/CIP1 and Bax, leading to
aberrant cell proliferation and cell viability [103]. HDAC1 and
HDAC3 are overexpressed in colon cancer cells and in primary
colon cancer, and siRNA (small interfering RNA) mediated
silencing of HDAC1 and HDAC3 in colon cancer cells induced
apoptosis [104].
MEF2C (myocyte enhancer factor 2C) is a member of the
MEF2 family of transcription factors. Recently, MEF2C was
identified as a potential oncogenic transcription factor associated
with CRC [24]. Besides, it has been shown that MEF2C was
hypermethylated. Also, it was indicated by the significantly down-
regulated in colon cancer that MEF2C may play a role in CRC
etiology [105].
NR1H3 is a transcription factor involved in lipid homeostasis
and inflammation. Recent evidences indicated that miRNAs can
bind to the 39untranslatedregions (UTRs) of mRNAs and regulates
their translation. Genetic polymorphisms can locate in miRNA
binding sites. Thus, miRNA regulation may be influenced by
polymorphisms on the 39UTRs. NR1H3 was identified as
Table 5. The overlap between 41 genes identified from three
different methods and 742 cancer genes.
Overlap with 742 Cancer
genes p-value
Our 41 genes 8
Top 41 mRMR genes 4 0.03965
Top 41 t-test genes 2 4.923e-05
doi:10.1371/journal.pone.0033393.t005
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sites which was associated with risk of sporadic CRC [106]. The
specific relationship between NR1H3 and CRC remains to be
further elucidated.
Overlap between selected genes and known cancer
genes as well as known CRC related genes
Statistic test showed that the overlap between the 41 genes
identified in our study and the 742 cancer-related genes we
compiled was quite significant (p-value=0.0001908). The KEGG
analysis result of such 41 genes also implied that they were
significantly enriched in cancer-related pathways (p-value=8.00E-
05). Taken together, it indicated that the 41 genes identified by us
were closely associated with cancer. In addition, the overlaps of
such 41 candidate genes with the previous (p-value=0.01057) and
recent (p-value=0.002017) reported CRC biomarkers were
significant. This suggested that the 41 candidate genes have the
potential to be used as biomarkers for CRC diagnosis.
In addition, we compared the 41 genes identified by us with the
top 41 genes in mRMR feature list and the top 41 differentially
expressed genes identified by the traditional t-test method of R
language [107]. See the Supporting Information S6 for such three
sets of 41 genes. As can be seen from there, the 41 genes identified
by us contain 8 cancer genes, which is more than 4 (p-
value=0.03965, proportion test) and 2 (p-value=4.923e-05,
proportion test) cancer genes than those contained in the 41
genes identified by mRMR and the 41 genes identified by the t-
test, respectively (Table 5).
Functional similarity between selected genes and known
CRC related genes
In this study, five gene sets were defined. The first gene set is our
41 selected genes. The second gene set is the top 41 mRMR genes.
The third gene set is the top 41 t-test genes that have the smallest t-
test p values. The second and third gene sets were from gene
expression profiles alone. Our 41 gene were selected based on both
gene expression profiles and protein interaction network. The
fourth gene set is the 742 cancer genes mentioned above. The fifth
gene set is the combined known CRC related genes of 742 cancer
related genes, 438 genes from Sabates-Bellver’s study [23]and 134
colorectal cancer related genes from Nagaraj’s study [24]. These
five gene sets can be found in the Supporting Information S6.
To compare the functional similarity between our selected genes
and the known CRC related genes, we constructed their functional
profiles using the 2log10 of the hypergeometric test p value on
Gene Ontology (GO) terms [1,5,108]. Then we calculated the
Pearson correlation coefficient of their functional profiles [1,109].
The functional similarities of the functional profiles for the five
gene sets were shown in Table 6. Our 41 genes had greater
functional similarity with the cancer genes and the known CRC
genes than the genes identified from gene expression profiles
alone: top 41 mRMR genes and top 41 t-test genes. This suggests
that the genes selected by our method are more reliable than the
genes identified from the gene expression profiles alone.
Combining the gene expression profiles and protein interaction
network together can improve the identification of disease genes.
The reason why our method can generate more reliable results is
becausethattheshortestpathwayapproachintegratedhereisbased
onalltheinformationofgenesfromdatabase,textmining,etc.thatis
quite stable and can avoid the false positives. In contrast to this, the
method based on the gene expression data can cause lots of false
positives.Itisanticipatedthatourmethodmaybecomeausefultool,
or at least play a complementary role to the existing method, for
identifying colorectal cancer genes.
It is instructive to point out that our method may have some
limitations.Thisisbecausesomehubgenesthatmaysimultaneously
interact with lots of other genes can also occur in our shortest path
and the randomly selected shortest paths, such as TP53 and EP300.
Nevertheless, our method can provide a p-value to evaluate the
significance that can be used to distinguish the hubs in the network
background.
Conclusion
Weproposedanovelmethodtoidentifycancerrelatedgenes.We
applied this method on CRC and identified 41 genes which had the
mostpotentialtobebiomarkerforCRCearlydiagnose.Statistictest
andKEGGanalysisshowedthatthe41candidategenesidentifiedin
our study are not only closely related to cancer but also have great
potential to become biomarker for CRC diagnosis. In addition, the
41 candidate genes contain more cancer genes than the genes
identified from gene expression profiles alone, and functional
similarity analysis revealed that our genes had greater functional
similarity with the reported CRC genes than the genes identified
from gene expression profiles alone. We believe that our method
maybehelpful(oratleastplayastimulativerole)forpredictingnovel
cancer related genes, and that it might have the potential
applicability for the cancer research.
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Table 6. The functional similarity between our 41 genes and
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Cancer genes Colorectal cancer genes
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*
Top 41 t-test genes 0.203573
* 0.269548
*
*Pearson correlation coefficient of functional profiles.
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